Myoglobin and troponin I as markers of myocardial damage during cardioversion of atrial fibrillation;Mioglobina i troponina I jako markery uszkodzenia miȩśnia sercowego podczas kardiowersji migotania przedsionków

Polskie Archiwum Medycyny Wewnetrznej

Volumn 110, Issue 2, 2003, Pages 827-836

  Kosior, Dariusz ^a   Chwyczko, Tomasz ^a   Stawicki, Sławomir ^a   Tadeusiak, Wiesław ^b   Rabczenko, Daniel ^c   Opolski, Grzegorz ^a  

^a WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c Instytutu Higieny   (Poland)

Author keywords

Atrial fibrillation; Biphasic schock; Electrical cardioversion; Monophasic schock; Myoglobin; Troponin I

Indexed keywords

MYOGLOBIN; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE MARKER; ENERGY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE MASS; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SKELETAL MUSCLE;

EID: 0042379662     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pritchett E.L.: Management of atrial fibrillation. N. Engl. J. Med., 1992, 326, 1264.
2. Levy S.: Cardioversion of chronic atrial fibrillation - towards more aggressive approach? Eur. Heart. J., 2000, 21, 263.
3. Prystowsky E.N.: Cardioversion of atrial fibrillation to sinus rhythm: who, when, how and why? Am. J. Cardiol., 2000, 86, 326.
4. Van Gelder I.C., Crijns H.J.G.M., Tieleman R.G. i wsp.: Value and limitation of electrical cardioversion in patients with chronic atrial fibrillation: importance of arrhythmia risk factors and oral anticoagulation. Arch. Intern. Med., 1996, 156, 2585.
5. Van Gelder I.C., Crijns H.J.G.M., Van Glist W.H. i wsp.: Prediction of uneventful cardioversion and maintenance of sinus rhythm after direct current cardioversion of chronic atrial fibrillation and flutter. Am. J. Cardiol., 1991, 68, 41.
6. Keener J. P., Lewis T.J.: The biphasic mystery: why a biphasic shock is more effective than a monophasic shock for defibrillation. J. Ther. Biol., 1999, 200, 1.
7. Mittal S., Ayati S.: Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine waye monophasic shocks. Circulation, 2000, 101, 1282.
8. Boriani G., Biffi M., Cervi V. i wsp.: Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest, 2000, 118, 342.
9. Lund M., French J.K., Johnson R.N. i wsp.: Serum troponins T and I after elective cardioversion. Eur. Heart. J., 2000, 21, 245.
10. Henry W.L. i wsp.: Report of the American Society of Echocardiography Committee on Nomenclature and Standards in two-dimentional Echocardiography. Circulation, 1980, 62, 212.
11. Sahn D.J., De Maria A., Kisslo J. i wsp.: Recommendations regarding quantitation in M-mode echocardiography. Results of survery of echocardiographic measurements. Circulation, 1978, 58, 1072.
12. Quinones M.A., Pickering E., Alexander J.K. i wsp.: Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining of ejection fraction and stroke volume. Chest, 1978, 74, 59.
13. Gordon E.P., Schnittger I., Fitzgerald P.J. i wsp.: Reproducibility of left ventricular volumes by two-dimensional echocardiography. JACC, 1983, 2, 506.
14. Ribeiro L.G., Quinones M.A., Reduto A.L. i wsp.: Assessment of left ventricular regional wall motion with two-dimentional echocardiography and gated cardiac imaging: comparison to angiography. Circulation, 1979, 59, (suppl. III), 137111.
15. Devereux R.B., Alonso D.R., Lutas E.M.: Echocardiographic assessment of left ventricular hypertrophy comparison necropsy findings. Am. J. Carciol., 1986, 57, 450.
16. Lown B., Kleiger R., Wolff G.: The technique of cardioversion. Am. Heart J., 1964, 67, 282.
17. Lown B., Amarasingham R., Neuman J.: New method for terminating cardiac arrythmias - use of a synchronized discharge. Jama, 1962, 182, 548.
18. Lown B., Perlroth M.G., Bey S.K.: Cardioversion of atrial fibrillation. A report of the treatment of 65 episodes in 50 patients. N. Engl. J. Med., 1063, 269, 325.
19. Opolski G., Torbicki A.: Migotanie przedsionków. (Urban & Partner, ed.) Wrocław, 2000.
20. Allall J.J., Feld R.D., Rusell A.A. i wsp.: Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J. Am. Coll. Cardiol., 1997, 30, 1052.
21. Wysokiński A., Zapolski T.: Effects of various methods of conversion of atrial fibrillation to sinus rhythm on systolic and diastolic left ventricular function. Kardiol. Pol., 2001, 54, 25.
22. Martins J.B., Gascho J.A., Kerber R.E. i wsp.: Effect of direct current counter shocks on regional myocardial contrictility and perfusion experimental studies. Circulation, 1981, 50, 323.
23. Dahl C., Esy G., Warmer E. i wsp.: Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation, 1974, 50, 956.
24. Doherty P.W., McLaughlin P.R., Billingham M. i wsp.: Cardiac damage produced by direct current countershock applied to the heart. Am. J. Cardiol., 1979, 43, 225.
25. Georges J.L., Spentchian M., Caubel C. i wsp.: Time course of troponin I, myoglobin, and cardiac enzyme release after electrical cardioversion. Am. J. Cardiol., 1996, 78, 825.
26. Vikenes K., Omwik P., Farstad M. i wsp.: Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am. Heart J., 2000, 25, 690.